Nifty
Sensex
:
:
15763.05
52586.84
-15.40 (-0.10%)
-66.23 (-0.13%)

Pharmaceuticals & Drugs - Domestic

Rating :
55/99

BSE: 506820 | NSE: ASTRAZEN

3369.50
30-Jul-2021
  • Open
  • High
  • Low
  • Previous Close
  •  3369.00
  •  3394.00
  •  3360.05
  •  3369.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  11142
  •  376.67
  •  4970.00
  •  3005.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,427.13
  • 90.32
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,074.77
  • 0.06%
  • 18.54

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 1.22%
  • 19.72%
  • FII
  • DII
  • Others
  • 2.42%
  • 0.94%
  • 0.70%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.36
  • 8.39
  • 3.76

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.17
  • 29.68
  • 13.70

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.79
  • 36.00
  • 19.66

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 95.41
  • 114.49
  • 112.36

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.76
  • 22.76
  • 22.76

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 51.49
  • 59.38
  • 63.67

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Net Sales
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

News Update:


  • AstraZeneca Pharma, Abbott Healthcare terminate distribution agreement
    28th May 2021, 11:53 AM

    Earlier, the Distribution agreement had entered into between both the companies for the distribution of Dapagliflozin, an innovative Type 2 diabetes medicine

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.